0000000000310036

AUTHOR

Ayşegül Erdem

0000-0002-5222-5928

showing 3 related works from this author

Survival in rhino-orbito-cerebral mucormycosis: An international, multicenter ID-IRI study

2022

International audience; BACKGROUND: Mucormycosis is an emerging aggressive mold infection. This study aimed to assess the outcome of hospitalized adults with rhino-orbito-cerebral mucormycosis (ROCM). The secondary objective was to identify prognostic factors in this setting. METHODS: This study was an international, retrospective, multicenter study. Patients’ data were collected from 29 referral centers in 6 countries. All qualified as "proven cases" according to the EORTC/MSGERC criteria. RESULTS: We included 74 consecutive adult patients hospitalized with ROCM. Rhino-orbito-cerebral type infection was the most common presentation (n = 43; 58.1%) followed by rhino-orbital type (…

AdultAntifungal AgentsSurveillanceNeutropeniaEpidemiologyMucormycosiInfectionsHospital-acquired infectionRhino-orbito-cerebral mucormycosisZygomycosis[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyDebridementRisk FactorsDiagnosisOrbital DiseasesRisk Factors.Internal MedicineHumansMucormycosisRhino-orbito-cerebral mucormycosiEye Infections FungalRetrospective Studies
researchProduct

Portraying infective endocarditis

2019

Infective endocarditis is a growing problem with many shifts due to ever-increasing comorbid illnesses, invasive procedures, and increase in the elderly. We performed this multinational study to depict definite infective endocarditis. Adult patients with definite endocarditis hospitalized between January 1, 2015, and October 1, 2018, were included from 41 hospitals in 13 countries. We included microbiological features, types and severity of the disease, complications, but excluded therapeutic parameters. A total of 867 patients were included. A total of 631 (72.8%) patients had native valve endocarditis (NVE), 214 (24.7%) patients had prosthetic valve endocarditis (PVE), 21 (2.4%) patients …

MaleInternationalityAucunInfective endocarditimedicine.disease_causeMedical microbiology80 and overBlood cultureHospital MortalityAged 80 and overmedicine.diagnostic_testbiologyEndocarditisSBacterialGeneral MedicineSciences bio-médicales et agricolesMiddle AgedStaphylococcal InfectionsSciences du Vivant [q-bio]/Microbiologie et ParasitologieViridans StreptococciCatheterInfectious Diseases[SDV.MP]Life Sciences [q-bio]/Microbiology and ParasitologyStaphylococcus aureusInfective endocarditisAortic ValveMitral ValveFemaleMicrobiology (medical)Adultmedicine.medical_specialtyProsthesis-Related InfectionsAdolescentaureusBlood cultureYoung AdultInternal medicinemedicineEndocarditisHumansresults of multinational ID-IRI study- EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES cilt.38 ss.1753-1763 2019 [Erdem H. Puca E. Ruch Y. Santos L. Ghanem-Zoubi N. Argemi X. Hansmann Y. Guner R. Tonziello G. Mazzucotelli J. et al. -Portraying infective endocarditis]ProstheticAgedNative Valve EndocarditisBacteriabusiness.industryEndocarditis Bacterialmedicine.diseasebiology.organism_classificationS. aureusViridans streptococciInfective endocarditisbusinessNative
researchProduct

Clinicopathological profile of gastrointestinal tuberculosis: a multinational ID-IRI study

2020

Data are relatively scarce on gastro-intestinal tuberculosis (GITB). Most studies are old and from single centers, or did not include immunosuppressed patients. Thus, we aimed to determine the clinical, radiological, and laboratory profiles of GITB. We included adults with proven GITB treated between 2000 and 2018. Patients were enrolled from 21 referral centers in 8 countries (Belgium, Egypt, France, Italy, Kazakhstan, Saudi Arabia, UK, and Turkey). One hundred four patients were included. Terminal ileum (n = 46, 44.2%), small intestines except terminal ileum (n = 36, 34.6%), colon (n = 29, 27.8%), stomach (n = 6, 5.7%), and perianal (one patient) were the sites of GITB. One-third of all p…

MaleCirrhosismedicine.medical_treatmentretrospective studylaparoscopyColonoscopymultimodal imagingComorbidityGastroenterologyprotionamide0302 clinical medicineLaparotomyAscitesamikacinMedicinebedaquilinePathologie maladies infectieusesintestine biopsyadultsteroidclinical trialGeneral MedicinerifabutinMicrobiologie et protistologie [entomologiephytoparasitolog.]priority journaldiabetes mellitushistopathologybiological productMicrobiology (medical)Microbiologie et protistologie [parasitologie hum. et anim.]medicine.medical_specialtyTuberculosis030106 microbiologymalignant neoplasmArticle03 medical and health scienceslaparotomyHuman immunodeficiency virus infectionmolecular diagnosisHumansTuberculosisGastro-intestinalhumanRetrospective Studiescolondisease predispositionmicrobiologyTuberculosis; Immune-suppression; Gastro-intestinal; Endoscopy;anusmedicine.diseasemajor clinical studymulticenter studyaminosalicylic acidcyclophosphamide0301 basic medicineBiopsyAntitubercular Agentsethambutolrifampicinterminal ileumcolonoscopyofloxacin030212 general & internal medicineLaparoscopyazathioprinemedicine.diagnostic_testIncidence (epidemiology)gastrointestinal tuberculosisDisease Managementchronic kidney failurecycloserineInfectious DiseasesfemaleTreatment OutcomeMolecular Diagnostic Techniquesdiagnostic testDisease Susceptibilitymedicine.symptommoxifloxacinSymptom AssessmentImmune-suppressionstomachisoniazidpyrazinamidestreptomycinliver cirrhosispatient referrallinezolidInternal medicineBiopsybusiness.industryEndoscopyMycobacterium tuberculosishuman tissueclinical featureTreatmentTuberculosis Gastrointestinaltuberculostatic agentbusinessMicrobiologie et protistologie [bacteriol.virolog.mycolog.]
researchProduct